73
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

Retigabine for partial onset seizures

&
Pages 509-517 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Andreas Schulze-Bonhage. (2017) A 2017 review of pharmacotherapy for treating focal epilepsy: where are we now and how will treatment develop?. Expert Opinion on Pharmacotherapy 18:17, pages 1845-1853.
Read now
Gaetano Zaccara, Fabio Giovannelli, Massimo Cincotta & Alfonso Iudice. (2013) AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel. Expert Review of Neurotherapeutics 13:6, pages 647-655.
Read now
Michael A Ciliberto, Judith LZ Weisenberg & Michael Wong. (2012) Clinical utility, safety, and tolerability of ezogabine (retigabine) in the treatment of epilepsy. Drug, Healthcare and Patient Safety 4, pages 81-86.
Read now

Articles from other publishers (5)

Deborah Guery & Sylvain Rheims. (2020) Is the mechanism of action of antiseizure drugs a key element in the choice of treatment?. Fundamental & Clinical Pharmacology 35:3, pages 552-563.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 155 177 .
Gökce Orhan, Merle Bock, Dorien Schepers, Elena I. Ilina, Stephanie Nadine Reichel, Heidi Löffler, Nicole Jezutkovic, Sarah Weckhuysen, Simone Mandelstam, Arvid Suls, Timm Danker, Elke Guenther, Ingrid E. Scheffer, Peter De Jonghe, Holger Lerche & Snezana Maljevic. (2014) Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy . Annals of Neurology 75:3, pages 382-394.
Crossref
Elinor Ben-Menachem. (2014) Medical management of refractory epilepsy-Practical treatment with novel antiepileptic drugs. Epilepsia 55, pages 3-8.
Crossref
Dorotheé G. A. Kasteleijn‐Nolst Trenité, Victor Biton, Jacqueline A. French, Bassel Abou‐Khalil, William E. Rosenfeld, Bree Diventura, Elizabeth L. Moore, Seth V. Hetherington & Greg C. Rigdon. (2013) K v7 potassium channel activation with ICA ‐105665 reduces photoparoxysmal EEG responses in patients with epilepsy . Epilepsia 54:8, pages 1437-1443.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.